EMILY SEWELL: Open Payments
NPI 1922374859 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,614 in 105 payments from 15 companies in 2025. Trend: 2023 $1,623 · 2024 $1,697 · 2025 $1,614
Food & beverage: $1,614
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $386 |
| ABBVIE INC. | 15 | $248 |
| Lilly USA, LLC | 14 | $168 |
| Madrigal Pharmaceuticals | 10 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| GENZYME CORPORATION | 5 | $96 |
| PFIZER INC. | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 8 | $71 |
| Ardelyx, Inc. | 3 | $64 |
Products named: TREMFYA, RINVOQ, OMVOH, REZDIFFRA, DUPIXENT, XIFAXAN, ENTYVIO, XELJANZ.
Industry payments across KY — which companies pay providers there.
